Evaluation of genetic variants in microRNA biosynthesis genes and risk of breast cancer in Chinese women

International Journal of Cancer

Volumn 133, Issue 9, 2013, Pages 2216-2224

  Jiang, Yue ^a   Chen, Jiaping ^a   Wu, Jiangping ^a   Hu, Zhibin ^a   Qin, Zhenzhen ^a   Liu, Xiao'An ^a   Guan, Xiaoxiang ^b   Wang, Yanru ^b   Han, Jing ^a   Jiang, Tao ^a   Jin, Guangfu ^a   Zhang, Mingfeng ^a   Ma, Hongxia ^a   Wang, Shui ^a   Shen, Hongbing ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

breast cancer risk; DGCR8; miRNA biosynthesis genes

Indexed keywords

LUCIFERASE; MICRORNA;

3' UNTRANSLATED REGION; ADULT; AGO2 GENE; ALLELE; ARTICLE; BINDING SITE; BREAST CANCER; CANCER RISK; CANCER STAGING; CELL FUNCTION; CHINESE; CONTROLLED STUDY; DGCR8 GENE; DICER GENE; DISEASE ASSOCIATION; DROSH GENE; FEMALE; GEMIN3 GENE; GEMIN4 GENE; GENE; GENETIC VARIABILITY; GENOTYPE; HISTOPATHOLOGY; HIWI GENE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RAN GENE; RNA BINDING; RNA SYNTHESIS; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST CANCER RISK; DGCR8; MIRNA BIOSYNTHESIS GENES;

3' UNTRANSLATED REGIONS; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; LUCIFERASES; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84882703648     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28237     Document Type: Article

References (36)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM,. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
2. Key TJ, Verkasalo PK, Banks E,. Epidemiology of breast cancer. Lancet Oncol 2001; 2: 133-40.
3. Yamashita H, Iwase H, Toyama T, Takahashi S, Sugiura H, Yoshimoto N, Endo Y, Fujii Y, Kobayashi S,. Estrogen receptor-positive breast cancer in Japanese women: trends in incidence, characteristics, and prognosis. Ann Oncol 2011; 22: 1318-25.
4. Yoshimoto N, Nishiyama T, Toyama T, Takahashi S, Shiraki N, Sugiura H, Endo Y, Iwasa M, Fujii Y, Yamashita H,. Genetic and environmental predictors, endogenous hormones and growth factors, and risk of estrogen receptor-positive breast cancer in Japanese women. Cancer Sci 2011; 102: 2065-72.
5. Iwasaki M, Otani T, Inoue M, Sasazuki S, Tsugane S,. Role and impact of menstrual and reproductive factors on breast cancer risk in Japan. Eur J Cancer Prev 2007; 16: 116-23.
6. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K,. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343: 78-85.
7. Long J, Shu XO, Cai Q, Gao YT, Zheng Y, Li G, Li C, Gu K, Wen W, Xiang YB, Lu W, Zheng W,. Evaluation of breast cancer susceptibility loci in Chinese women. Cancer Epidemiol Biomarkers Prev 2010; 19: 2357-65.
8. Sun T, Hu Z, Shen H, Lin D,. Genetic polymorphisms in cytotoxic T-lymphocyte antigen 4 and cancer: the dialectical nature of subtle human immune dysregulation. Cancer Res 2009; 69: 6011-4.
9. Hu Z, Liang J, Wang Z, Tian T, Zhou X, Chen J, Miao R, Wang Y, Wang X, Shen H,. Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 2009; 30: 79-84.
10. Murphy D, Dancis B, Brown JR,. The evolution of core proteins involved in microRNA biogenesis. BMC Evol Biol 2008; 8: 92.
11. Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, Nishikura K, Shiekhattar R,. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005; 436: 740-4.
12. Yue J, Tigyi G,. MicroRNA trafficking and human cancer. Cancer Biol Ther 2006; 5: 573-8.
13. Ryan BM, Robles AI, Harris CC,. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 2010; 10: 389-402.
14. Gregory RI, Shiekhattar R,. MicroRNA biogenesis and cancer. Cancer Res 2005; 65: 3509-12.
15. Parker JS, Roe SM, Barford D,. Structural insights into mRNA recognition from a PIWI domain-siRNA guide complex. Nature 2005; 434: 663-6.
16. Lewis BP, Burge CB, Bartel DP,. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
17. Calin GA, Croce CM,. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-66.
18. Ratner E, Lu L, Boeke M, et al. A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk. Cancer Res 2010; 70: 6509-15.
19. Zhang W, Winder T, Ning Y, et al. A let-7 microRNA-binding site polymorphism in 3′-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy. Ann Oncol 2011; 22: 104-9.
20. Zhang S, Chen H, Zhao X, Cao J, Tong J, Lu J, Wu W, Shen H, Wei Q, Lu D,. REV3L 3′UTR 460 T>C polymorphism in microRNA target sites contributes to lung cancer susceptibility. Oncogene 2013; 32: 242-50.
21. Lin Y, Nie Y, Zhao J, Chen X, Ye M, Li Y, Du Y, Cao J, Shen B, Li Y,. Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility. Carcinogenesis 2012; 33: 2377-83.
22. Xiong F, Wu C, Chang J, Yu D, Xu B, Yuan P, Zhai K, Xu J, Tan W, Lin D,. Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer. Cancer Res 2011; 71: 5175-81.
23. Kim JS, Choi YY, Jin G, et al. Association of a common AGO1 variant with lung cancer risk: a two-stage case-control study. Mol Carcinog 2010; 49: 913-21.
24. Yang H, Dinney CP, Ye Y, Zhu Y, Grossman HB, Wu X,. Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer. Cancer Res 2008; 68: 2530-7.
25. Liang D, Meyer L, Chang DW, Lin J, Pu X, Ye Y, Gu J, Wu X, Lu K,. Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response. Cancer Res 2010; 70: 9765-76.
26. Lin J, Horikawa Y, Tamboli P, Clague J, Wood CG, Wu X,. Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma. Carcinogenesis 2010; 31: 1805-12.
27. Horikawa Y, Wood CG, Yang H, Zhao H, Ye Y, Gu J, Lin J, Habuchi T, Wu X,. Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin Cancer Res 2008; 14: 7956-62.
28. Jiang Y, Shen H, Liu X, Dai J, Jin G, Qin Z, Chen J, Wang S, Wang X, Hu Z,. Genetic variants at 1p11.2 and breast cancer risk: a two-stage study in Chinese women. PLoS One 2011; 6: e21563.
29. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T,. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 2007; 39: 673-7.
30. Sung H, Lee KM, Choi JY, Han S, Lee JY, Li L, Park SK, Yoo KY, Noh DY, Ahn SH, Kang D,. Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea. Breast Cancer Res Treat 2011; 130: 939-51.
31. Han J, Lee Y, Yeom KH, Nam JW, Heo I, Rhee JK, Sohn SY, Cho Y, Zhang BT, Kim VN,. Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell 2006; 125: 887-901.
32. Han J, Pedersen JS, Kwon SC, Belair CD, Kim YK, Yeom KH, Yang WY, Haussler D, Blelloch R, Kim VN,. Posttranscriptional crossregulation between Drosha and DGCR8. Cell 2009; 136: 75-84.
33. Zhang X, Cairns M, Rose B, O'Brien C, Shannon K, Clark J, Gamble J, Tran N,. Alterations in miRNA processing and expression in pleomorphic adenomas of the salivary gland. Int J Cancer 2009; 124: 2855-63.
34. Sand M, Skrygan M, Georgas D, Arenz C, Gambichler T, Sand D, Altmeyer P, Bechara FG,. Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer. Mol Carcinog 2012; 51: 916-22.
35. Pan S, Yu F, Gong C, Song E,. Tumor invasion and metastasis initiated by mir-106b in breast cancer by targeting BRMS1 and RB. Cancer Res 2009; 69: 3.
36. Landgraf P, Rusu M, Sheridan R, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007; 129: 1401-14.